Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Other Operating Expense : ¥78.9 Mil (TTM As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi C&Y Pharmaceutical Group Co Other Operating Expense?

Shanxi C&Y Pharmaceutical Group Co's Other Operating Expense for the three months ended in Jun. 2024 was ¥33.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥78.9 Mil.

Shanxi C&Y Pharmaceutical Group Co's quarterly Other Operating Expense declined from Dec. 2023 (¥83.8 Mil) to Mar. 2024 (¥-1.7 Mil) but then increased from Mar. 2024 (¥-1.7 Mil) to Jun. 2024 (¥33.4 Mil).

Shanxi C&Y Pharmaceutical Group Co's annual Other Operating Expense declined from Dec. 2021 (¥85.2 Mil) to Dec. 2022 (¥84.6 Mil) but then increased from Dec. 2022 (¥84.6 Mil) to Dec. 2023 (¥87.4 Mil).

Shanxi C&Y Pharmaceutical Group Co Other Operating Expense Historical Data

The historical data trend for Shanxi C&Y Pharmaceutical Group Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi C&Y Pharmaceutical Group Co Other Operating Expense Chart

Shanxi C&Y Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

89.84

90.49

85.15

84.58

87.44

Shanxi C&Y Pharmaceutical Group Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Operating Expense	Get a 7-Day Free Trial															39.02	-36.62	83.82	-1.68	33.42

Shanxi C&Y Pharmaceutical Group Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥78.9 Mil.

Shanxi C&Y Pharmaceutical Group Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shanxi C&Y Pharmaceutical Group Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi C&Y Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi C&Y Pharmaceutical Group Co Ltd (SZSE:300254) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010

Website

http://www.cy-pharm.com

Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.

Executives

Zuo Xue Min	Supervisors
Huang Le Qun	Director
Zhang Zhen Biao	Executives
Yu Jun Xian	Directors, Directors, and Executives
Zhao Qun	Director
Weng Zhan Guo	Director
Geng Chun Feng	Director
Pang Xiao Quan	Supervisors
Zhong Hai Rong	Directors, executives
Xuan Hang	Director

Shanxi C&Y Pharmaceutical Group Co Headlines

No Headlines